Household Healthcare Sector

Clarity Pharmaceuticals

Market Cap: AU$700.5m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

PYC Therapeutics

Market Cap: AU$699.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Bioventus

Market Cap: US$450.6m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

Claritev

Market Cap: US$450.0m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

Paragon Care

Market Cap: AU$695.2m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

REGENXBIO

Market Cap: US$445.9m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Cullinan Therapeutics

Market Cap: US$442.6m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Septerna

Market Cap: US$438.5m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Zenas BioPharma

Market Cap: US$438.0m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Personalis

Market Cap: US$437.2m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Capricor Therapeutics

Market Cap: US$431.5m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Sage Therapeutics

Market Cap: US$431.5m

A biopharmaceutical company, develops and commercializes brain health medicines.

Amylyx Pharmaceuticals

Market Cap: US$431.4m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Oxford Biomedica

Market Cap: UK£320.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Precigen

Market Cap: US$428.0m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

SIGA Technologies

Market Cap: US$427.9m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Tourmaline Bio

Market Cap: US$425.4m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Treace Medical Concepts

Market Cap: US$422.7m

A medical technology company, designs, manufactures, and markets medical devices in the United States.

EyePoint Pharmaceuticals

Market Cap: US$421.8m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

PureTech Health

Market Cap: UK£314.2m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Verastem

Market Cap: US$417.1m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Northwest Biotherapeutics

Market Cap: US$416.6m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Knight Therapeutics

Market Cap: CA$577.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Verve Therapeutics

Market Cap: US$412.7m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Standard BioTools

Market Cap: US$410.2m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Surmodics

Market Cap: US$408.7m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Vitalhub

Market Cap: CA$569.0m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Maze Therapeutics

Market Cap: US$405.1m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Fortrea Holdings

Market Cap: US$402.0m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Celcuity

Market Cap: US$401.8m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

MeiraGTx Holdings

Market Cap: US$401.0m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Sana Biotechnology

Market Cap: US$393.6m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Tectonic Therapeutic

Market Cap: US$391.9m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Organogenesis Holdings

Market Cap: US$390.7m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Australian Clinical Labs

Market Cap: AU$605.1m

Provides pathology diagnostic services in Australia.

Prothena

Market Cap: US$386.5m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.